Lithostat (Mission Pharmacal Company)
Welcome to the PulseAid listing for the Lithostat drug offered from Mission Pharmacal Company. This Urease Inhibitor [EPC],Urease Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mission Pharmacal Company |
| NON-PROPRIETARY NAME: | acetohydroxamic acid |
| SUBSTANCE NAME: | ACETOHYDROXAMIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Urease Inhibitor [EPC],Urease Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1983-05-31 |
| END MARKETING DATE: | 0000-00-00 |
Lithostat HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lithostat from Mission Pharmacal Company |
| LABELER NAME: | Mission Pharmacal Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 1983-05-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0178-0500_6660b616-a82d-9109-19ce-2bdf9747acea |
| PRODUCT NDC: | 0178-0500 |
| APPLICATION NUMBER: | NDA018749 |
Other ACETOHYDROXAMIC ACID Pharmaceutical Manufacturers / Labelers:
